Literature DB >> 32110668

Complex liver retransplantation to treat graft loss due to long-term biliary tract complication after liver transplantation: A case report.

Jiang Li1, Qing-Jun Guo2, Wen-Tao Jiang2, Hong Zheng2, Zhong-Yang Shen2.   

Abstract

BACKGROUND: Loss of graft function after liver transplantation (LT) inevitably requires liver retransplant. Retransplantation of the liver (ReLT) remains controversial because of inferior outcomes compared with the primary orthotopic LT (OLT). Meanwhile, if accompanied by vascular complications such as arterial and portal vein (PV) stenosis or thrombosis, it will increase difficulties of surgery. We hereby introduce our center's experience in ReLT through a complicated case of ReLT. CASE
SUMMARY: We report a patient who suffered from hepatitis B-associated cirrhosis and underwent LT in December 2012. Early postoperative recovery was uneventful. Four months after LT, the patient's bilirubin increased significantly and he was diagnosed with an ischemic-type biliary lesion caused by hepatic artery occlusion. The patient underwent percutaneous transhepatic cholangial drainage and repeatedly replaced intrahepatic biliary drainage tube regularly for 5 years. The patient developed progressive deterioration of liver function and underwent liver re-transplant in January 2019. The operation was performed in a classic OLT manner without venous bypass. Both the hepatic artery and PV were occluded and could not be used for anastomosis. The donor PV was anastomosed with the recipient's left renal vein. The donor hepatic artery was connected to the recipient's abdominal aorta. The bile duct reconstruction was performed in an end-to-end manner. The postoperative process was very uneventful and the patient was discharged 1 mo after retransplantation.
CONCLUSION: With the development of surgical techniques, portal thrombosis and arterial occlusion are no longer contraindications for ReLT. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Arterial occlusion; Biliary tract complication; Case report; Graft liver failure; Ischemic type biliary lesion; Liver retransplantation; Portal vein thrombosis

Year:  2020        PMID: 32110668      PMCID: PMC7031839          DOI: 10.12998/wjcc.v8.i3.568

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  27 in total

1.  [Indications and results of liver retransplantation: experience with 1181 patients at the University Hospital La Fe].

Authors:  Rodrigo Torres-Quevedo; Angel Moya-Herraiz; Fernando San Juan; Jairo Rivera; Rafael López-Andujar; Eva Montalvá; Eugenia Pareja; Manuel De Juan; Victoria Aguilera; Marina Berenguer; Martín Prieto; José Mir
Journal:  Cir Esp       Date:  2010-05-07       Impact factor: 1.653

2.  Auxiliary reno-portal anastomosis in living donor liver transplantation: a technique for recipients with low portal inflow.

Authors:  Sami Akbulut; Cuneyt Kayaalp; Mehmet Yilmaz; Sezai Yilmaz
Journal:  Transpl Int       Date:  2012-04-05       Impact factor: 3.782

3.  Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom.

Authors:  Michael A Silva; Periyathambi S Jambulingam; Bridget K Gunson; David Mayer; John A C Buckels; Darius F Mirza; Simon R Bramhall
Journal:  Liver Transpl       Date:  2006-01       Impact factor: 5.799

4.  Trends and experiences in liver retransplantation over 15 years.

Authors:  Robert Pfitzmann; Birgit Benscheidt; Jan Michael Langrehr; Guido Schumacher; Ruth Neuhaus; Peter Neuhaus
Journal:  Liver Transpl       Date:  2007-02       Impact factor: 5.799

Review 5.  Retransplantation of the liver: review of current literature for decision making and technical considerations.

Authors:  P S Yoo; V Umman; M I Rodriguez-Davalos; S H Emre
Journal:  Transplant Proc       Date:  2013-04       Impact factor: 1.066

6.  Prognostic Factors and Outcomes of Patients After Liver Retransplantation.

Authors:  Ł Masior; M Grąt; M Krasnodębski; W Patkowski; W Figiel; E Bik; M Krawczyk
Journal:  Transplant Proc       Date:  2016-06       Impact factor: 1.066

7.  Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.

Authors:  Jennifer A Flemming; W Ray Kim; Carol L Brosgart; Norah A Terrault
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

8.  Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience.

Authors:  Hideya Kamei; Mamoun Al-Basheer; Jeffrey Shum; Michael Bloch; William Wall; Douglas Quan
Journal:  J Surg Res       Date:  2013-07-31       Impact factor: 2.192

9.  Decision for retransplantation of the liver: an experience- and cost-based analysis.

Authors:  Daniel Azoulay; Marcello M Linhares; Emmanuel Huguet; Valérie Delvart; Denis Castaing; René Adam; Philippe Ichai; Faouzi Saliba; Antoinette Lemoine; Didier Samuel; Henri Bismuth
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

10.  Have we changed the liver retransplantation survival?

Authors:  C B Bellido; J M Á Martínez; G S Artacho; L M M Gómez; J S Diez-Canedo; L B Pulido; J M P Acevedo; J P Ruiz; M A G Bravo
Journal:  Transplant Proc       Date:  2012 Jul-Aug       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.